| Literature DB >> 29234497 |
A Shariati1, T Azimi2, A Ardebili3,4, A S Chirani2, A Bahramian2, A Pormohammad2, M Sadredinamin2, S Erfanimanesh5, N Bostanghadiri2, S Shams6, A Hashemi2.
Abstract
In this study, we report the insertion sequence ISPpu21 in the oprD porin gene of carbapenem-resistant Pseudomonas aeruginosa isolates from burn patients in Tehran, Iran. Antibiotic susceptibility tests for P. aeruginosa isolates were determined. Production of metallo-β-lactamases (MBLs) and carbapenemase was evaluated and the β-lactamase-encoding and aminoglycoside-modifying enzyme genes were investigated by PCR and sequencing methods. The mRNA transcription level of oprD and mex efflux pump genes were evaluated by real-time PCR. The outer membrane protein profile was determined by SDS-PAGE. The genetic relationship between the P. aeruginosa isolates was assessed by random amplified polymorphic DNA PCR. In all, 10.52% (10/95) of clinical isolates of P. aeruginosa harboured the ISPpu21 insertion element in the oprD gene. The extended-spectrum β-lactamase-encoding gene in ISPpu21-carrying isolates was blaTEM. PCR assays targeting MBL and carbapenemase-encoding genes were also negative in all ten isolates. The rmtA, aadA, aadB and armA genes were positive in all ISPpu21 harbouring isolates. The relative expression levels of the mexX, mexB, mexT and mexD genes in ten isolates ranged from 0.1- to 1.4-fold, 1.1- to 3.68-fold, 0.3- to 8.22-fold and 1.7- to 35.17-fold, respectively. The relative expression levels of the oprD in ten isolates ranged from 0.57- to 35.01-fold, which was much higher than those in the control strain P. aeruginosa PAO1. Evaluation of the outer membrane protein by SDS-PAGE suggested that oprD was produced at very low levels by all isolates. Using random amplified polymorphic DNA PCR genotyping, eight of the ten isolates containing ISPpu21 were shown to be clonally related. The present study describes a novel molecular mechanism, ISPpu21 insertion of the oprD gene, associated with carbapenem resistance in clinical P. aeruginosa isolates.Entities:
Keywords: Burn; ISPpu21; OprD porin; Pseudomonas aeruginosa; carbapenem
Year: 2017 PMID: 29234497 PMCID: PMC5722278 DOI: 10.1016/j.nmni.2017.10.013
Source DB: PubMed Journal: New Microbes New Infect ISSN: 2052-2975
DNA sequences used in PCR and real-time RT-PCR
| Primer | Sequence (5′→3′) | Expected size of amplicon (bp) | Reference |
|---|---|---|---|
| ATGAAAGTGATGAAGTGGAG | 1329 | ||
| CGCCGACATCAGCAACACC | 195 | ||
| CAAGGGCGTCGGTGACTTCCAG | 297 | ||
| CTCGAGCTATACGTGCCTAAC | 79 | ||
| TGTCAGTGATCCTATGCCCC | 165 | This study | |
| GGCTTGGTGGAAGACGTG | 64 | ||
| GGCGTGCGTTACCACACCGT | 92 | ||
| TEM | TCGGGGAAATGTGCGCG | 972 | |
| SHV | TTAGCGTTGCCAGTGCTC | 861 | |
| CTX-M | TTTGCGATGTGCAGTACCAGTAA | 544 | |
| VEB | CGACTTCCATTTCCCGATGC | 643 | |
| GES | TTGCAATGTGCTCAACGTTC | 351 | This study |
| KPC | CGTCTAGTTCTGCTGTCTTG | 798 | |
| IMP | GAAGGCGTTTATGTTCATAC | 587 | |
| VIM | GATGGTGTTTGGTCGCATA | 390 | |
| NDM | GGTTTGGCGATCTGGTTTTC | 621 | |
| GIM | TCGACACACCTTGGTCTGAA | 477 | |
| SPM | AAAATCTGGGTACGCAAACG | 271 | |
| CTAGCGTCCATCCTTTCCTC | 635 | ||
| ATGAGGGAAGCGGTGATCG | 320 | ||
| ATGGACACAACGCAGGTCGC | 120 | ||
| TGGGAAGTTAAAGACGACGA | 212 |
Fig. 1PCR amplification of oprD gene from carbapenem-resistant Pseudomonas aeruginosa. M, DNA Ladder 100 bp; N, negative control; P, P. aeruginosa PAO1 strain; lane 4, oprD gene; lanes 2,3,5–9, ISPpu21/oprD combination.
Antibiotic susceptibility, PCR results for genes and gene expression data for ISPpu21-carrying Pseudomonas aeruginosa isolates
| Isolate | MIC (μg/mL) | ESBL genes | MBL genes | Aminoglycoside-Modifying Enzyme Genes | Relative expression levels | Inserted into | IS | RAPD-PCR | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CO | GEN | AK | IMP | MEM | CAZ | CIP | mexX | mexB | mexD | mexT | oprD | |||||||
| PA11 | ≤2 | 256 | 64 | 8 | 64 | 128 | 16 | − | aadA- aadB- rmtA-armA | 1.2 | 1.1 | 21.11 | ND | 12.22 | + | + | A | |
| PA17 | ≤2 | 128 | 32 | 4 | 128 | 128 | 32 | − | aadA- aadB-rmtA | 2.1 | 1.2 | 35.17 | 0.97 | 10.25 | + | + | A | |
| PA22 | ≤2 | 32 | 32 | 256 | 64 | 128 | 16 | − | aadA- aadB- rmtA-armA | 1.3 | 1.1 | 1.7 | 0.89 | 0.57 | + | + | A | |
| PA31 | ≤2 | 32 | 32 | 256 | 128 | 128 | 128 | − | aadA- aadB-armA | 1.2 | 1.3 | 4.56 | 0.35 | 1.37 | + | + | A | |
| PA42 | ≤2 | 256 | 256 | 256 | 128 | 64 | 32 | − | aadA- aadB- rmtA-armA | 1.2 | 1.1 | 19.2 | 8.22 | 30.36 | + | + | A | |
| PA43 | ≤2 | 256 | 256 | 256 | 128 | 128 | 32 | − | aadA- aadB- rmtA-armA | 1.3 | 1.1 | 4.22 | 2.07 | 16.14 | + | + | A | |
| PA46 | ≤2 | 256 | 256 | 256 | 8 | 64 | 4 | − | aadA- aadB- rmtA-armA | 0.18 | 1.2 | 15.24 | 2.31 | 25.56 | + | + | C | |
| PA48 | ≤2 | 128 | 256 | 4 | 8 | 256 | 8 | − | aadA- aadB- rmtA-armA | 0.53 | 1.2 | 23.57 | 1.06 | 9.01 | + | + | A | |
| PA49 | ≤2 | 32 | 256 | 4 | 8 | 16 | 16 | − | aadA- rmtA | 1.4 | ND | ND | ND | 4.07 | + | + | A | |
| Psa6 | ≤2 | 256 | 256 | 4 | 4 | 4 | 16 | − | aadA- rmtA- | 1.10 | 3.68 | 2.21 | 2.36 | 35.01 | + | + | B | |
Abbreviations: GEN, gentamicin; AK, amikacin; IMP, imipenem; MEM, meropenem; CAZ, cefotaxime; CIP, ciprofloxacin; ESBL, extended-spectrum β-lactamases; MBL, metallo-β-lactamases; RAPD-PCR, random amplified polymorphic DNA polymerase chain reaction.
–, Negative; +, Positive; ND, not determined.
Fig. 2Random amplified polymorphic DNA-PCR fingerprints of Pseudomonas aeruginosa isolates from burn patients using primer 272. M, DNA molecular weight marker (1 kb); N, negative control; 1–12, clinical samples.